Table 5.
Complication | n (%) | Action |
---|---|---|
Clavien grade I, | ||
Persitence of voiding dysfunction | 1 (2) | Observation |
Clavien grade II, | ||
Recurrent UTIs. | 2 (4) | Antimicrobial prophylaxis or therapy |
De novo OAB | 10 (22.2) | Antimuscarinics/ß-agonists |
Clavien grade III, | ||
Asymptomatic vaginal mesh exposure | 1 (2) | Topical estrogen plus surgical intervention without mesh excision |
Symptomatic vaginal mesh exposure | 1 (2) | Topical estrogen plus surgical intervention without mesh excision |